EE197 Efficacy and Economic Impact of Metformin Plus Glibenclamide Treatment During the COVID-19 Pandemic in Ecuadorian Outpatients With Type II Diabetes Mellitus

Detalles Bibliográficos
Autores principales: Zambrano, R, Cabezas, M, Loor, G, Aguirre, N, Miño, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747433/
http://dx.doi.org/10.1016/j.jval.2022.09.447
_version_ 1784849597100720128
author Zambrano, R
Cabezas, M
Loor, G
Aguirre, N
Miño, C
author_facet Zambrano, R
Cabezas, M
Loor, G
Aguirre, N
Miño, C
author_sort Zambrano, R
collection PubMed
description
format Online
Article
Text
id pubmed-9747433
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-97474332022-12-14 EE197 Efficacy and Economic Impact of Metformin Plus Glibenclamide Treatment During the COVID-19 Pandemic in Ecuadorian Outpatients With Type II Diabetes Mellitus Zambrano, R Cabezas, M Loor, G Aguirre, N Miño, C Value Health Article Published by Elsevier Inc. 2022-12 2022-12-14 /pmc/articles/PMC9747433/ http://dx.doi.org/10.1016/j.jval.2022.09.447 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zambrano, R
Cabezas, M
Loor, G
Aguirre, N
Miño, C
EE197 Efficacy and Economic Impact of Metformin Plus Glibenclamide Treatment During the COVID-19 Pandemic in Ecuadorian Outpatients With Type II Diabetes Mellitus
title EE197 Efficacy and Economic Impact of Metformin Plus Glibenclamide Treatment During the COVID-19 Pandemic in Ecuadorian Outpatients With Type II Diabetes Mellitus
title_full EE197 Efficacy and Economic Impact of Metformin Plus Glibenclamide Treatment During the COVID-19 Pandemic in Ecuadorian Outpatients With Type II Diabetes Mellitus
title_fullStr EE197 Efficacy and Economic Impact of Metformin Plus Glibenclamide Treatment During the COVID-19 Pandemic in Ecuadorian Outpatients With Type II Diabetes Mellitus
title_full_unstemmed EE197 Efficacy and Economic Impact of Metformin Plus Glibenclamide Treatment During the COVID-19 Pandemic in Ecuadorian Outpatients With Type II Diabetes Mellitus
title_short EE197 Efficacy and Economic Impact of Metformin Plus Glibenclamide Treatment During the COVID-19 Pandemic in Ecuadorian Outpatients With Type II Diabetes Mellitus
title_sort ee197 efficacy and economic impact of metformin plus glibenclamide treatment during the covid-19 pandemic in ecuadorian outpatients with type ii diabetes mellitus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747433/
http://dx.doi.org/10.1016/j.jval.2022.09.447
work_keys_str_mv AT zambranor ee197efficacyandeconomicimpactofmetforminplusglibenclamidetreatmentduringthecovid19pandemicinecuadorianoutpatientswithtypeiidiabetesmellitus
AT cabezasm ee197efficacyandeconomicimpactofmetforminplusglibenclamidetreatmentduringthecovid19pandemicinecuadorianoutpatientswithtypeiidiabetesmellitus
AT loorg ee197efficacyandeconomicimpactofmetforminplusglibenclamidetreatmentduringthecovid19pandemicinecuadorianoutpatientswithtypeiidiabetesmellitus
AT aguirren ee197efficacyandeconomicimpactofmetforminplusglibenclamidetreatmentduringthecovid19pandemicinecuadorianoutpatientswithtypeiidiabetesmellitus
AT minoc ee197efficacyandeconomicimpactofmetforminplusglibenclamidetreatmentduringthecovid19pandemicinecuadorianoutpatientswithtypeiidiabetesmellitus

Ejemplares similares